<DOC>
	<DOC>NCT01494402</DOC>
	<brief_summary>The purpose of this study is to assess bioequivalence between D961S and esomeprazole/buffered ASA, safety, tolerability of esomeprazole in combination with ASA and pharmacokinetics (PK) of D961S, esomeprazole and buffered ASA following repeated administration in healthy male Japanese subjects.</brief_summary>
	<brief_title>Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects</brief_title>
	<detailed_description>A Phase I, Open label, Randomized, Single center, 2 way Crossover Bioequivalence Study Comparing D961S (a Fixed-dose Combination Capsule of Esomeprazole 20 mg and Acetylsalicylic Acid 81 mg) with a Free Combination of Esomeprazole Capsule 20 mg + Buffered Acetylsalicylic Acid Tablet 81 mg After Repeated Oral Administration in Japanese Healthy Male Subjects</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy Japanese males 2045 years of age Classified as homoEM Negative for HIV, Hepatitis B, Hepatitis C and syphilis Body Mass Index (BMI=weight/height2) 1927 (kg/m2) Body weight 5085 kg Significant clinical illness from 2 weeks preceding the preentry visit to the randomization Past or present cardiac, renal, hepatic, neurological or gastrointestinal disease Need for concomitant medication in the study Past or present NSAIDs induced asthma History of bleeding diathesis</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Healthy volunteer, Japanese males, homo-EM</keyword>
</DOC>